In 2022, the global Bee Venom Extract Market is estimated at $327.5 million. The market is expected to reach nearly $540 million by 2032, with a growing CAGR of 5.1% from 2022 to 2032.

Bee venom, also known as apitoxin, is a colorless and bitter liquid. According to the American Apitherapy Association, bee therapy or apitherapy is the therapeutic use of products made by honey bees such as bee venom extract and bees. Bee venom treatment uses the venom of bees to treat diseases that do not respond to traditional Western medicine. Few of the functions of bee venom are healing arthritis, anti-inflammatory, relieving pain, and other claims include acne, psoriasis, and scarring from skin cancer. It takes almost 10,000 bee stings to produce one gram of bee venom. That makes poison almost seven times more valuable than gold.

Download example [email protected] https://www.futuremarketinsights.com/reports/sample/rep-gb-3991

Global Bee Venom Extracts Market: Drivers and Constraints

One of the major factors driving the bee venom market is the extensive use of the pharmaceuticals. For example, bee venom has been used in Europe for several decades, primarily to treat rheumatic diseases. Both the live bees and the venom extracts are used for treatment in Europe.

People also get into the bee venom business as it is one of the most profitable businesses and the collector can increase their income by almost 200%. Another important factor affecting the bee venom market is the innovation in the bee extraction devices that make it easier for the manufacturers to extract the bee venom from the hive. The device fits under the brood chamber of a bee colony.

However, the main limitation in collecting the bee venom is the husbandry techniques and this leads to the death of the bee if not handled properly. This causes his spike to fall into the catcher. In the past, the bees were trapped when the bees returned to their hive. She…